Trial NCT04385095 ; EudraCT 2020-001023-14
Publication Monk PD, Lancet Respir Med, 2020
Primary outcome on the report: change in clinical condition on the WHO Ordinal Scale for Clinical Improvement (OSCI) during the dosing period

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.